. The present study was designed to ascertain in children with asthma (i) whether salbutamol given as aerosol inhalation is an effective bronchodilator; (ii) whether it differs from isoprenaline in effectiveness or duration of action; (iii) whether it differs from isoprenaline in its effect on pulse rate.
Subjects and Methods
Ten children who attended out-patients regularly were selected; their ages ranged from 5 to 13 years. There were 6 girls and 4 boys, all of whom were considered on clinical grounds to be severe or moderately severe asthmatics. They attended on six separate occasions receiving a single inhalation each visit, taking placebo, salbutamol, and isoprenaline on two occasions each. They had no treatment for 24 hours before the experiments were carried out. The trial was doubleblind, and the order in which the children received the various drugs was randomly decided. The aerosol canisters were lettered, the results were analysed, and the canisters decoded after the trial was completed.
Respiratory function tests. Measurements were made of forced expiratory volume in I second (FEV1., , ) and the forced vital capacity (FVC) using an Air-Shields Pulmonary Function Recorder. The children rested for 15 minutes and then the three resting values were taken at 15-minute intervals; the aerosol was then given and further measurements made at 5, 10, 60, and 120 minutes. On each occasion 3 values of FVC and FEV1.0 were taken.
Each child received a single inhalation from the canister, the doses being as follows: salbutamol 100 ,ug., and isoprenaline 100 jtg.
The placebo contained Arcton 11 and Arcton 12 with a small amount of oleic acid as a surfactant. The children were seated during the investigation and appeared able to co-operate easily.
The to 67-9%. There were only two ratios over 65 /-one of 67-9% and the other of 66-7%. These have been included together with those which were below 65%1, the conventional lower limit of normal. Of the 22 abnormal ratios the number of occasions on which the various drugs were subsequently given were:-isoprenaline 9, salbutamol 7, and placebo 6.
Pulse rates. These were measured by palpation of the radial artery for 30 seconds immediately before the respiratory function tests.
Results
Airways obstruction. Table III compares the differences between salbutamol and isoprenaline. Isoprenaline and salbutamol were equally effective at 5 and 10 minutes; salbutamol was significantly better than isoprenaline at 60 and 120 minutes. 
Discussion
The results show that aerosol administration of 100 ,ug. salbutamol produced a useful improvement in reversible airways obstruction which was of the same order as isoprenaline 100 [tg., whereas placebo had no significant effect. The duration of action of salbutamol was longer than that of isoprenaline, evidence of the effect being apparent at 2 hours, with little indication of decline. This is probably explained by the fact that salbutamol is absorbed from the gastro-intestinal tract (Warrell et al., 1970) in contrast to isoprenaline. Any portion of the salbutamol which is not inhaled will usually be swallowed and thus still be capable of exerting an effect. In addition, salbutamol is relatively resistant to metabolic breakdown or inactivation, significant quantities being excreted unchanged in the urine after inhalation (Kennedy and Simpson, 1969) . The prolonged action of salbutamol has been shown in adults, where effects up to 5 hours have been observed (Riding et al., 1969; Choo-Kang et al., 1969) .
No tachycardia was observed with either salbutamol or isoprenaline at this dosage, even at 5 minutes. Studies in adults have shown the effect on pulse to be evident at this time for isoprenaline (Choo-Kang et al., 1969; Kelman et al., 1969) . It is probable that in the children reported here insufficient quantities of either drug had been given to cause tachycardia. There is no evidence in man that bronchodilatation occurs with lower circulating levels of isoprenaline than are required to produce tachycardia, and the marked bronchodilatation found in our patients is presumptive evidence of adequate drug absorption. However, the response to isoprenaline is known to be extremely variable and what appears a more likely explanation is that, in children, especially during attacks of bronchospasm, the heart rate is so labile that the naturally occurring variations in rate are as great as those occurring after a sympathomimetic agent. It is thus reasonable to conclude that in children at doses of 100 ,ug. isoprenaline and salbutamol do not cause tachycardia, but nevertheless produce clinically useful improvement in airways obstruction.
Our conclusions are that salbutamol is to be preferred to isoprenaline because of its longer duration of action. In asthmatic children when isoprenaline and salbutamol were administered in the standard aerosol dosage, no tachycardia was demonstrated.
